P1225: The interplay of donor-derived gut microbiota correlates with the efficacy of combination therapy of fecal microbiota transplantation with antibiotics for ulcerative colitisECCO'24Year: 2024
Authors: IshikawaMD- phD, D.(1,2)*;Nomura, K.(1);Zhang, X.(1);kouma, M.(1);Maruyama, T.(1);Shibuya, T.(1);Watanabe, H.(2);Yamada, T.(2);Nagahara, A.(1,2);
(1)Juntendo University, Department of Gastroenterology, Tokyo, Japan;(2)Juntendo University, Department of Regenerative Microbiology, Tokyo, Japan;
P1226: Determination of oral and gut mucosal microbiome profiles of patients with treatment-naïve ulcerative colitisECCO'24Year: 2024
Authors: Karakan, T.(1)*;Özmeriç Kurtuluş, N.(2);Ünsal, B.(2);Çağrı İşler, S.(2);Akça, G.(3);Soysal, F.(2);Cindoruk, M.(1);Elgün Ulkar, S.(4);Açık, L.(5);Ergin, M.(1);Abbasov, Z.(1);Özkul Koçak, C.(6);ekmen, N.(1);Yalınay, A.M.(7);Özkan, S.(8);Karataş, A.(1); Paes Batista Da Silva, A.(9);
(1)Gazi University Faculty of Medicine, Gastroenterology, Ankara, Turkey;(2)Gazi University Faculty of Dentistry, Periodontology, Ankara, Turkey;(3)Gazi University Faculty of Dentistry, Microbiology, Ankara, Turkey;(4)Ankara University Faculty of Medicine, Medical Biochemistry, Ankara, Turkey;(5)Gazi University Faculty of Medicine, Molecular Biology and Genetics, Ankara, Turkey;(6)Hacettepe University- Faculty of Pharmacology, Pharmaceutical Microbiology, Ankara, Turkey;(7)Gazi University Faculty of Medicine, Medical Microbiology, Ankara, Turkey;(8)Gazi University Faculty of Medicine, Public Health, Ankara, Turkey;(9)Case Western Reserve University, Periodontology, Ohio, United States;
P1227: Revealing lower capacity of microbial metabolism of flavonoids and associated metabolic changes in Crohn’s diseaseECCO'24Year: 2024
Authors: Xiang, L.(1)*;Zhuo, S.(2);Luo, W.(3);Tian, C.(1);Feng, R.(1);Zhu, Y.(3);Chen, M.(1);
(1)The First Affiliated Hospital- Sun Yat-sen University, Department of Gastroenterology, Guangzhou, China;(2)The First Affiliated Hospital- Sun Yat-sen University, Department of Nutrition, Guangzhou, China;(3)The First Affiliated Hospital- Sun Yat-sen University, Institute of Precision Medicine, Guangzhou, China;
P1228: The EISER Study: Identifying Microbial Factors Associated with Subclinical Gut Inflammation in Psoriatic Arthritis Patients Who Develop Inflammatory Bowel DiseaseECCO'24Year: 2024
Authors: Marín Jimenez, I.(1)*;Boix-Amorós, A.(2);Blank, R.B.(3);Cantor, A.(4);Sanz Sanz, J.(5);Gutiérrez-Casbas, A.(6);Gratacós, J.(7);Rodríguez-Lago, I.(8);Trujillo, E.(9);Plaza, Z.(10);Domínguez-Álvaro, M.(10);Díaz-González, F.(9);Cañete, J.D.(11);Scher, J.U.(3);Clemente, J.C.(2);
(1)General University Hospital Gregorio Marañón, Department of Gastroenterology and Digestive System Medicine, Madrid, Spain;(2)Icahn School of Medicine at Mount Sinai-, Department of Genetics and Genomic Sciences- and Precision Immunology Institute, New York, United States;(3)New York University Grossman School of Medicine, Division of Rheumatology- Department of Medicine and Psoriatic Arthritis Center, New York, United States;(4)Icahn School of Medicine at Mount Sinai, Department of Genetics and Genomic Sciences- and Precision Immunology Institute, New York, United States;(5)Hospital Universitario Puerta de Hierro- Majadahonda, Rheumatology Department, Madrid, Spain;(6)Hospital General Universitario de Dr. Balmis de Alicante Servicio Digestivo- ISABIAL y CIBERehd, Gastroenterology department, Alicante, Spain;(7)University Hospital Parc Taulí- Sabadell, Rheumatology Department, Barcelona, Spain;(8)Hospital Universitario Galdakao-Usansolo, Gastroenterology department, Galdakao, Spain;(9)Hospital Universitario de Canarias- La Laguna, Rheumatology Department, Santa Cruz de Tenerife, Spain;(10)Spanish Society of Rheumatology, Research Unit, Madrid, Spain;(11)Hospital Clinic y Fundació Clinic-IDIBAPS, Rheumatology Department, Barcelona, Spain;
P1229: The Role and Niche-Specific Adaptation of Malassezia in patients with Ulcerative colitisECCO'24Year: 2024
Authors: ShinShin, S.(1)*;Cho, Y.J.(2);Yang, J.(3);Kim, H.K.(4);Rintarhat, P.(3);Park, M.(3);Lagree, K.(5);Underhill, D.M.(5);Yang, C.S.(4);Moon, J.M.(1);Seo, J.(1);Kim, K.(1);Jung, W.H.(3);Choi, C.H.(1);
(1)Chung-Ang University College of Medicine, Internal medicine, Seoul, Korea- Republic Of;(2)Kangwon National University, Molecular Bioscience, Kangwondo, Korea- Republic Of;(3)Chung-Ang University, Systems Biotechnology, Anseong, Korea- Republic Of;(4)Hanyang University, Molecular and Life Science, Ansan, Korea- Republic Of;(5)Cedars-Sinai Medical Center, Biomedical Sciences, Los Angeles, United States;
P122: Digital spatial profiling reveals the predictive characteristics in patients with immune checkpoint inhibitor-induced colitisECCO'24Year: 2024
Authors: Shi, Q.(1,2)*;Zeng, Y.(1,2);Zhou, Q.(1);Liu, X.(1,3);Tang, H.(1);Lu, B.(1);Qian, J.(1);Chen, M.(4);Xu, Y.(4);Wang, M.(4);Tan, B.(1);
(1)Peking Union Medical College Hospital- Peking Union Medical College & Chinese Academy of Medical Science, Department of Gastroenterology, Beijing, China;(2)Tsinghua University, School of Medicine, Beijing, China;(3)Peking Union Medical College & Chinese Academy of Medical Science, Peking Union Medical College, Beijing, China;(4)Peking Union Medical College Hospital- Peking Union Medical College & Chinese Academy of Medical Science, Department of Respiratory and Critical Care Medicine, Beijing, China;
P1230: Integrated analysis of microbiome and metabolome reveals disease-specific profiles in inflammatory bowel disease and intestinal Behcet’s diseaseECCO'24Year: 2024
Authors: Park, Y.(1)*;Ahn, J.B.(2);Kim, S.W.(3);Kim, W.H.(4);Cheon, J.H.(2);
(1)Ewha Womans University Seoul Hospital, Departments of Internal Medicine- Institute of Gastroenterology, Seoul, Korea- Republic Of;(2)Yonsei University College of Medicine, Department of Internal Medicine, Seoul, Korea- Republic Of;(3)Yonsei University College of Medicine, Brain Korea 21 PLUS Project for Medical Science, Seoul, Korea- Republic Of;(4)Hanaro Medical Foundation, Department of Internal Medicine, Seoul, Korea- Republic Of;
P1232: Alterations in microbial composition in patients with newly diagnosed Crohn@E@s disease over a course of one year: data from a prospective longitudinal real-world studyECCO'24Year: 2024
Authors: Sharar Fischler, T.(1,2)*;Reshef, L.(3);Godny, L.(1,2); Freidenberg, A.(1,2); Pauker, M.(1,2);Rabinowitz, K.(4);Avni-Biron, I.(1,2);Gophna, U.(3);Dotan, I.(1,2);Yanai, H.(1,2);
(1)Rabin Medical Center, IBD Center- Division of Gastroenterology, Petah Tikva, Israel;(2)Tel Aviv University, Faculty of Medicine, Tel Aviv, Israel;(3)Tel Aviv University, The George S. Wise Faculty of Life Sciences, Tel Aviv, Israel;(4)Tel Aviv University, Felsenstein Medical Research Center- Faculty of Medicine, Tel Aviv, Israel;
P1233: Serum insulin is associated with c-reactive protein and gut microbial diversity in inflammatory bowel diseaseECCO'24Year: 2024
Authors: Wark, G.(1)*;O. Kaakoush, N.(2);Samocha-Bonet , D.(3);Ghaly, S.(4);Danta, M.(5);
(1)School of Medicine- St Vincent@E@s Healthcare Campus- Faculty of Medicine & Health, University of New South Wales, Sydney, Australia;(2)School of Biomedical Sciences- Faculty of Medicine & Health, University of New South Wales, Sydney, Australia;(3)Garvan Institute of Medical Research, Garvan Institute of Medical Research, Sydney, Australia;(4)Department of Gastroenterology and Hepatology, St Vincent’s Hospital, Sydney, Australia;(5)School of Clinical Medicine- St Vincent’s Healthcare Campus- Faculty of Medicine & Health, University of New South Wales, Sydney, Australia;
P1234: The gut microbiome as a reporter of health, and its associations with different exposuresECCO'24Year: 2024
Authors: Braun, T.(1);Hadar, R.(1);Efroni, G.(1);Haaronian, O.(1);Leshem, R.(1);Amit, S.(2);Abbas-Egbariya, H.(1);Truma, K.(3);Segev, S.(3);Amir, A.(1);Haberman Ziv, Y.(1)*;
(1)Sheba Medical Center- affiliated with the Tel Aviv University, Department of Pediatric Gastroenterology, Ramat Gan, Israel;(2)Sheba Medical Center- affiliated with the Tel Aviv University, Microbiology, Ramat Gan, Israel;(3)Sheba Medical Center- affiliated with the Tel Aviv University, Screening clinic, Ramat Gan, Israel;
P1236: Oral microbiota dysbiosis in Inflammatory Bowel Disease patientsECCO'24Year: 2024
Authors: Rodrigues, C.(1)*;Gomes, A.(2);Mendes, K.(2);Correia, M.J.(2);Pereira, P.(2);C. Lopes, P.(2);Martins, R.(2);Veiga, N.(2);Rosa, N.(2);Soares, C.(1);Ministro, P.(1);
(1)Centro Hospitalar Tondela-Viseu, Gastroenterology Department, Viseu, Portugal;(2)Universidade Católica Portuguesa- Faculty of Dental Medicine, Center for Interdisciplinary Research in Health, Viseu, Portugal;
P1237: Development of an algorithm to identify the best donor-recipient match for FMT in IBD patients based on immune system/microbiota interactionsECCO'24Year: 2024
Authors: Facciotti, F.(1,2)*; Amoroso, C.(3);Strati, F.(4);Caridi, B.(5);Perillo, F.(6);Noviello, D.(5,7);Vecchi, M.(3,5);Caprioli, F.(3,5);
(1)European Institute of Oncology, Experimental Oncology, Milano, Italy;(2)University of Milano-Bicocca, Biotechnology and Biosciences, Milan, Italy;(3)Fondazione IRCCS Cà Granda- Ospedale Maggiore Policlinico, Gastroenterology and Endoscopy Unit, Milan, Italy;(4)University of Milano Bicocca, Biotechnology and Biosciences, Milan, Italy;(5)University of MIlan, Pathophysiology and Transplantation, Milan, Italy;(6)European Institute of Oncology, experimental oncology, Milan, Italy;(7)Fondazione IRCCS Cà Granda- Ospedale Maggiore Policlinico-, Gastroenterology and Endoscopy Unit, Milan, Italy;
P1238: Exploring the Role of Klebsiella variicola and Klebsiella pneumoniae in Pediatric Ulcerative Colitis PathogenesisECCO'24Year: 2024
Authors: Arjomand Fard, N.(1)*;Bording-Jorgensen, M.(2);Cheng, C.(2);Kerr, K.(2);Aujla, H.(2);Mansour, S.(3);Elhenawy, W.(3);Perry, T.(4);Wine, E.(5);
(1)University of Alberta, Physiology, Edmonton, Canada;(2)University of Alberta, Department of Pediatrics, Edmonton, Canada;(3)University of Alberta, Department of Medical Microbiology & Immunology, Edmonton, Canada;(4)University of Alberta, Department of Surgery, Edmonton, Canada;(5)University of Alberta, Department of Pediatrics and Physiology, Edmonton, Canada;
P1240: Systematic review with meta-analysis: faecal microbiota transplantation as treatment of chronic pouchitisECCO'24Year: 2024
Authors: Cold, F.(1)*;Halkjær, S.I.(1);Lo, B.(1);Lauridsen, K.G.(2);Kousgaard, S.J.(3);Thorlacius-Ussing, O.(3);Petersen, A.M.(1);
(1)Copenhagen University Hospital Hvidovre, Gastrounit- Medical Division, Hvidovre, Denmark;(2)Copenhagen University Hospital Hvidovre, Department of Clinical Microbiology, Hvidovre, Denmark;(3)Aalborg University Hospital-, Department of Gastrointestinal Surgery, Aalborg, Denmark;
P1242: Pediatric IBD microbiome and microbial profiles formed within the familyECCO'24Year: 2024
Authors: Dovrolis, N.(1);Moschoviti, A.(2);Karamanolis, G.(3)*;Fessatou, S.(2);Kolios, G.(4);Gazouli, M.(5);
(1)Laboratory of Pharmacology- Department of Medicine, Democritus University of Thrace- Alexandroupolis- Greece, Alexandroupolis, Greece;(2)Medical School- National and Kapodistrian University of Athens, Third Department of Pediatrics- “Attikon” General University Hospital, Athens, Greece;(3)Medical School- National andKapodistrian University of Athens, Gastroenterology Unit- Second Department of Surgery- Aretaieio Hospital, Athens, Greece;(4)Democritus University of Thrace- Alexandroupolis, Laboratory of Pharmacology- Department of Medicine, Alexandroupolis, Greece;(5)Medical School- National and Kapodistrian University of Athens, Laboratory of Biology- Department of Basic Medical Sciences, Athens, Greece;
P124: Tissue Factor and Protease-Activated Receptor 2 associated genes are upregulated in patients with Inflammatory Bowel DiseaseECCO'24Year: 2024
Authors: Qiu, Y.(1);Yao, L.(1);Taylor Meadows, K.(1);Rey, D.(1);Khalid, M.(2)*;Travis, S.(3);
(1)Endpoint Health, Research, Palo Alto, United States;(2)Endpoint Health, Portfolio Strategy & Scientific Affairs, London, United Kingdom;(3)National Institute for Health and Care Research Oxford Biomedical Research Centre- University of Oxford, Translational Gastroenterology Unit and Kennedy Institute, Oxford, United Kingdom;
P125: MIG (CXCL9) and IL22 are key biomarkers that discriminates between paediatric IBD patients and non-IBD patients in a novel biomarker modelECCO'24Year: 2024
Authors: Eindor, A.(1)*;Tsai, K.(2);Jacobson, K.(3);
(1)Shamir medical center affiliated to Tel Aviv university, Division of Gastroenterology- Hepatology and Nutrition, Tel Aviv, Israel;(2)BC children@E@s hospital research institute, Pediatric Gastroenterology- Hepatology and Nurtition, Vancouver, Canada;(3)BC Children@E@s hospital, Pediatric Gastroenterology- Hepatology and Nutrition, Vancouver, Canada;
